P1EA34.SA Healthpeak Properties Inc.
- Market cap
- BRL 77.6B
- P/E
- 38.8x
- P/B
- 1.69x
- ROE
- 6.3%
- Dividend yield
- 4.26%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is P1EA34.SA undervalued?
Graham numberP1EA34.SA trades 70.7% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Healthpeak Properties Inc. fundamental analysis
No fundamental analysis for Healthpeak Properties Inc. yet.
Healthpeak Properties Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Healthpeak Properties Inc.
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery. Healthpeak Properties, Inc. is based in Denver, Colorado. Healthpeak Properties, Inc. was incorporated in 1985 in Maryland.
Full company profileHealthpeak Properties Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Healthpeak Properties Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 1.85B | 2.00B | 1.64B | 1.90B | 2.06B | 2.18B | 2.70B | 2.82B | 3.05B |
| Gross Profit | 1.14B | 1.12B | 862M | 1.12B | 1.20B | 1.29B | 1.63B | 1.70B | 1.74B |
| Operating Income | 495M | 365M | 215M | 340M | 656M | 426M | 290M | 521M | 495M |
| EBITDA | 1.87B | 937M | 1.13B | 971M | 1.39B | 1.27B | 1.61B | 1.65B | 2.03B |
| Net Income | 1.06B | 45.5M | 414M | 506M | 500M | 306M | 243M | 71.3M | 493M |
| EPS | 2.22 | 0.09 | 0.77 | 0.94 | 0.92 | 0.56 | 0.35 | 0.10 | 0.71 |
| Balance Sheet | |||||||||
| Total Assets | 12.7B | 14.0B | 15.9B | 15.3B | 15.8B | 15.7B | 19.9B | 20.3B | 21.7B |
| Total Liabilities | 6.21B | 7.37B | 8.58B | 8.11B | 9.12B | 8.77B | 10.9B | 12.0B | 12.2B |
| Shareholders' Equity | 5.94B | 6.09B | 6.79B | 6.52B | 6.65B | 6.35B | 8.40B | 7.50B | 7.84B |
| Cash & Short-term Investments | 111M | 144M | 44.2M | 158M | 72.0M | 118M | 120M | 467M | 1.63B |
| Cash Flow | |||||||||
| Operating Cash Flow | 849M | 846M | 758M | 795M | 900M | 956M | 1.07B | 1.25B | 1.24B |
| Capital Expenditure | 0.00 | 0.00 | 1.96B | 2.09B | 1.04B | 747M | 604M | 1.38B | 0.00 |
| Free Cash Flow | 849M | 846M | 758M | 795M | 900M | 956M | 1.07B | 1.25B | 1.24B |
| Ratios | |||||||||
| ROE | 17.9% | 0.7% | 6.1% | 7.8% | 7.5% | 4.8% | 2.9% | 1.0% | 6.3% |
| ROA | 8.3% | 0.3% | 2.6% | 3.3% | 3.2% | 1.9% | 1.2% | 0.4% | 2.3% |
| Net Profit Margin | 57.5% | 2.3% | 25.1% | 26.7% | 24.3% | 14.0% | 9.0% | 2.5% | 16.2% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Healthpeak Properties Inc. dividends
- Dividend yield
- 4.26%
- Forward dividend
- 4.45 BRL
- Payout ratio
- 1,190.1%
- Ex-dividend date
- Nov 12, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 849M | 1.22 | 1,190.1% |
| 2024 | USD 795M | 1.14 | 326.9% |
| 2023 | USD 657M | 1.20 | 214.7% |
| 2022 | USD 648M | 1.19 | 129.5% |
| 2021 | USD 650M | 1.21 | 128.6% |
| 2020 | USD 787M | 1.46 | 190.3% |
| 2019 | BRL 720M | 1.43 | 1,581.6% |
| 2018 | BRL 697M | 1.46 | 65.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Healthpeak Properties Inc.
- Insiders 0.00%
- Institutions 0.00%
- Public & others 100.00%
- Shares outstanding 690M
- Free float 687M
Healthpeak Properties Inc. company profile
- Company name
- Healthpeak Properties Inc.
- Ticker
- P1EA34.SA
- Exchange
- Sao Paulo Exchange
- Sector
- Real Estate
- Industry
- Diversified REITs
- Employees
- 411
- Fiscal year end
- December
- Address
- 4600 South Syracuse Street, Denver, CO, United States, 80237
- Phone
- (720) 428-5050
- Website
- healthpeak.com
About Healthpeak Properties Inc.
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery. Healthpeak Properties, Inc. is based in Denver, Colorado. Healthpeak Properties, Inc. was incorporated in 1985 in Maryland.
Healthpeak Properties Inc. management
10- Mr. Scott M. BrinkerPresident, CEO & Director · born 1977
- Mr. Kelvin O. MosesChief Financial Officer · born 1989
- Mr. Adam G. MabryChief Investment Officer · born 1985
- Ms. Tracy A. PorterExecutive VP, General Counsel & ESG · born 1978
- Mr. Scott R. BohnChief Development Officer & Head of Lab · born 1980
- Mr. Shawn G. JohnstonExecutive VP & Chief Accounting Officer · born 1980
- Mr. Andrew Johns CFASenior Vice President of Investor Relations
- Mr. James A. CroySenior Vice President of Leasing - Outpatient Medical
- Ms. Michelle WoodSenior VP, CFO and Controller of Senior Housing & Lab
- Mr. R. Justin HillSenior Vice President of Outpatient Medical